-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

901. Health Services Research—Non-Malignant Conditions: Poster III Clinically Relevant Abstract

Program: Oral and Poster Abstracts
Type: Poster
Hematology Disease Topics & Pathways:
Adult, Anemias, Biological, Bleeding Disorders, Coronaviruses, CRS, SARS-CoV-2/COVID-19, sickle cell disease, aplastic anemia, bacterial, Bleeding and Clotting, Diseases, GVHD, Therapies, Genetic Disorders, ITP, Pediatric, Hemoglobinopathies, iron deficiency, MPN, Thrombosis, gene therapy, Immune Disorders, Technology and Procedures, Young Adult, immunotherapy, Infectious Diseases, Study Population, Thromboembolism, Clinically relevant, Myeloid Malignancies, imaging, Quality Improvement , transplantation, VTE, VWD
Monday, December 7, 2020: 7:00 AM-3:30 PM

Ryan M Thomas, MD1*, Insu Koh, PhD2*, Katherine Wilkinson, MS3*, Nicholas Roetker, PhD4*, Nicholas L Smith, PhD5*, Allen B Repp, MD2*, Chris E. Holmes, MD, PhD2, Timothy B Plante, MD, MHS2*, Mary Cushman, MD, MSc6 and Neil A. Zakai, MD, MSc7

1University of Vermont Medical Center, Burlington
2Larner College of Medicine at the University of Vermont, Burlington, VT
3College of Medicine University of Vermont, Burlington, VT
4CDRG, Minneaopollis
5University of Washington, Seattle, WA
6Department of Medicine and Department of Pathology and Laboratory Medicine, Larner College of Medicine at the University of Vermont, Colchester, VT
7Department of Medicine and Department of Pathology & Laboratory Medicine, Larner College of Medicine at the University of Vermont, Burlington, VT

Leah E Masselink, PhD1*, Alfred Ian Lee, MD, PhD2 and Clese E Erikson, MPAff3*

1Department of Health Policy & Management, George Washington University, Washington, DC
2Section of Hematology, Department of Internal Medicine, Yale University School of Medicine and Yale Cancer Center, New Haven, CT
3Fitzhugh Mullan Institute for Health Workforce Equity, George Washington University, Washington, DC

Nicolas Galllastegui Crestani, MD1*, Jenny Y Zhou, MD1, Annette von Drygalski, MD, Pharm D1,2 and Timothy A Morris, MD3*

1Department of Medicine, Division of Hematology/Oncology, University of California San Diego, San Diego, CA
2Department of Molecular Medicine, The Scripps Research Institute, La Jolla, CA
3Department of Medicine, Division of Pulmonary and Critical Care Medicine, University of California San Diego, San Diego, CA

Katherine Steckham, MD1*, Craig Ainsworth, MD1*, Siraj Mithoowani, MD1 and Deborah M Siegal, MD2

1Department of Medicine, McMaster University, Hamilton, ON, Canada
2Department of Medicine, Thrombosis Clinic - Juravinski Hospital, Ottawa, ON, Canada

Wilson Andres Vasconez, M.D.1,2, Claudia Aguilar-Velez, M.D.3*, Cristina Matheus, M.D.3*, Marie Anne Sosa, M.D.4*, Yvonne Diaz, M.D.4*, Prasanth Narahari, M.D.3*, Roxana D Middleton, M.D.3*, Shanique Sterling, M.D.3*, Brent Rogers, M.D.3*, Vanessa Plunkett, R.N.5* and Hector Chavez, M.D.6*

1Pediatrics, University of Miami/Jackson Memorial Hospital, Miami, FL
2University of Miami/Jackson Memorial Hospital, Miami, FL
3University of Miami/Jackson Memorial Hospital, Miami
4University of Miami, Miami
5Jackson Memorial Hospital, Miami
6Jackson Memorial Hospital, Miami, FL

Benjamin Andrick, PharmD1*, Anupama Mathur, PharmD, BCOP1*, Tristan Maiers, PharmD, BCOP1*, Jove Graham, PhD2* and Joseph Vadakara, MD3

1Hematology/Oncology, Enterprise Pharmacy, Geisinger Medical Center, Danville, PA
2Center for Pharmacy Innovations & Outcomes, Geisinger, Danville, PA
3Cancer Institute, Geisinger Medical Center, Danville, PA

Mansour Gergi, MD1, Katherine Wilkinson, MS2*, Insu Koh, PhD3*, Jordan Munger4*, Nicholas L Smith, PhD5*, Nicholas Roetker, PhD6*, Mary Cushman7*, Allen B Repp, MD3*, Chris E. Holmes, MD, PhD1,3 and Zakai A Neil, MD8,9*

1University of Vermont Medical Center, Burlington, VT
2College of Medicine University of Vermont, Burlington, VT
3Larner College of Medicine at the University of Vermont, Burlington, VT
4Larner College of Medicine University of Vermont, Burlington, VT
5University of Washington, Seattle, WA
6Chronic Disease Research Group, Hennepin Research Institute, Minneapolis, MN
7University of Vermont, Colchester, VT
8Department of Pathology & Laboratory Medicine, University of Vermont, Burlington, VT
9Department of Medicine, Larner College of Medicine, University of Vermont, Burlington, VT

Eric Wittbrodt1*, Juan Jesus Carrero2*, Glen James3*, Steven Fishbane4*, Supriya R. Kumar1*, Roberto Pecoits-Filho5,6*, Juan Jose Garcia Sanchez3*, Carol A. Pollock7*, James A. Sloand1*, Katarina Hedman8* and David C. Wheeler9*

1AstraZeneca, Gaithersburg, MD
2Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden
3AstraZeneca, Cambridge, United Kingdom
4Department of Medicine, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Great Neck, NY
5Arbor Research Collaborative for Health, Ann Arbor, MI
6School of Medicine, Pontifical Catholic University of Parana, Curitiba, Brazil
7Royal North Shore Hospital, St. Leonards, NSW, Australia
8AstraZeneca, Gothenburg, Sweden
9University College London, London, United Kingdom

Alexander T Cohen, MBBS MSc MD FRACP FESC1,2*, Janvi Sah, MS3*, Theodore Lee, MD4*, Gail Wygant, RN5*, Lisa Rosenblatt, MD, MPH5*, Patrick Hlavacek, MPH6*, Birol Emir, PhD7*, Allison Keshishian, MPH3*, Rachel Delinger, MPH3* and Xuemei Luo, PhD8*

1Department of Hematological Medicine, Guy's and St Thomas' Hospitals, King's College, London, London, United Kingdom
2Department of Hematological Medicine, Guys and St Thomas/NHS Foundation Trust, London, GBR
3STATinMED Research, Ann Arbor, MI
4Pifzer Inc., New York, NY
5Bristol-Myers Squibb Company, Lawrenceville, NJ
6Pfizer Inc., New York, NY
7Pfizer, Inc., New York, NY
8Pfizer Inc., Groton, CT

Marcelo Barreto Lopes1*, Charlotte Tu1*, Jarcy Zee1*, Murilo H. Guedes2*, Ronald L. Pisoni1*, Bruce M. Robinson1*, Katarina Hedman3*, Glen James4*, James A. Sloand5*, Ziad Massy6*, Antonio A. Lopes7*, Helmut Reichel8*, Sandra Wächter9*, Michelle M. Wong10* and Roberto Pecoits-Filho1*

1Arbor Research Collaborative for Health, Ann Arbor, MI
2Pontificia Universidade Catolica do Parana, Curitiba, Brazil
3AstraZeneca, Gothenburg, Sweden
4AstraZeneca, Cambridge, United Kingdom
5AstraZeneca, Gaithersburg, MD
6Universite Paris-Saclay, Villejuif, France
7Universidade Federal da Bahia, Salvador, Brazil
8Nephrological Center, Villingen Schwenningen, Germany
9Vifor Pharma Ltd, Glattbrugg, Switzerland
10The University of British Columbia Faculty of Medicine, Vancouver, BC, Canada

Jeanne M. Palmer, Md1, Carolyn Mead-Harvey, MS2*, Claire Harrison, DM, FRCPath3, Amylou C. Dueck, PhD2, Ryan Eckert, MS4*, Heidi E. Kosiorek, MS2*, Pablo Muxi, MD5*, Naveen Pemmaraju, MD6, Guillermo Ruiz Arguelles7*, Alessandro Vannucchi, MD8, Vikas Gupta, MD, FRCP, FRCPath9, John Mascarenhas, MD10, Kerry Taylor, MBBS(Hons) FRACP FRCPA11, Krisstina L. Gowin, DO12, Holly L. Geyer, MD13*, Kazuya Shimoda, MD, PhD14, Jean-Jacques Kiladjian, MD, PhD15*, Norio Komatsu, MD, PhD16, Grace Kam Li Shan, MBBS17*, Virginia Abello, MD18*, David Gomez-Almaguer, MD 19, Robyn M. Scherber, MD20, Qian Jiang, MD21, Xuelan Zuo22*, Jennifer Huberty, PhD23*, Lesley Anderson, MD24*, Blake T. Langlais, MS2*, Ann Brazeau25*, Michelle Woehrle26*, Michael J. Mauro, MD27 and Ruben Mesa, MD28

1Mayo Clinic, Phoenix, AZ
2Department of Health Sciences Research, Mayo Clinic, Scottsdale, AZ
3Department of Clinical Haematology, Guys and St Thomas NHS Trust, London, United Kingdom
4Mays Cancer Center at UT Health San Antonio MD Anderson, San Antonio, TX
5British Hospital, Montevideo, Uruguay
6Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
7Centro de Hematología y Medicina Interna, Puebla, Mexico
8CRIMM; Center for Research and Innovation of Myeloproliferative Neoplasms, AOU Careggi, Department of Experimental and Clinical Medicine, University of Florence, Firenze, Italy
9Leukemia Program, Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada
10Hematology, Mount Sinai School of Medicine, New York, NY
11Mater Hospital, Brisbane, Australia
12Department of Hematology, University of Arizona, Tucson
13Mayo Clinic, Scottsdale, AZ
14Department of Gastroenterology and Hematology, Faculty of Medicine, University of Miyazaki, Miyazaki, Japan
15Université de Paris, Clinical Investigations Center, Saint-Louis hospital, APHP, Paris, FRA
16Department of Hematology, Juntendo University Graduate School of Medicine, Tokyo, Japan
17Singapore General Hospital, Singapore, Singapore
18Hospital de San José, Bogota, Colombia
19Universidad Autonoma de Nuevo Leon, Hospital Universitario "Dr. José Eleuterio Gonzalez", Monterrey, Mexico
20Incyte Corporation, Wilmington, DE
21Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China
22Department of Hematology, Zhongnan Hospital of Wuhan University, Wuhan, China
23School of Nutrition and Health Promotion, Arizona State University, Phoenix, AZ
24Centre for Public Health, Queens University, Belfast, United Kingdom
25MPN Advocacy and Education, Chicago, IL
26MPN Research Foundation, Chicago, IL
27Myeloproliferative Neoplasms Program, Leukemia Service, Memorial Sloan Kettering Cancer Center, New York, NY
28UT Health San Antonio Cancer Center, San Antonio, TX

Jonathan C. Roberts, MD1, Roshni Kulkarni, MD2, Peter A. Kouides, MD3, Robert F. Sidonio Jr., MD, MSc.4, Shannon L Carpenter, MD5, Barbara A. Konkle, MD6, Joanne Wu, MD, MS7*, Judith Baker, DrPH, MHSA8*, Megan M. Ullman, MA, MPH9*, Randall Curtis, MBA10*, Steven Carrasco, MPH11*, Duc Quang Tran Jr., MD12 and Michael B. Nichol, PhD11*

1Bleeding & Clotting Disorders Institute, Peoria, IL
2Michigan State University Center for Bleeding and Clotting Disorders, East Lansing, MI
3Mary M. Gooley Hemophilia Center, Inc, Rochester, NY
4Emory University & Children's Healthcare of Atlanta, Atlanta, GA
5Children's Mercy Kansas City, Kansas City, MO
6University of Washington, Washington Center for Bleeding Disorders, Seattle, WA
7University Of Southern California, Los Angeles, CA
8Center For Inherited Blood Disorders, Orange, CA
9Gulf States Hemophilia & Thrombophilia Center, University of Texas Health Science Center at Houston, Houston, TX
10Factor VIII Computing, Berkeley, CA
11University of Southern California, Los Angeles, CA
12Emory University, Hemophilia of Georgia Center for Bleeding & Clotting Disorders of Emory, Atlanta, GA

Anushka Bhaskar1* and Nathan T. Connell, MD, MPH2,3

1Harvard College, Cambridge, MA
2Harvard Medical School, Boston, MA
3Hematology Division, Department of Medicine, Brigham and Women's Hospital, Boston, MA

Ruben A. Mesa, MD, FACP1, Erin M. Sullivan, PhD2*, David Dubinski, MBA, BS2*, Brittany Carroll, MBA3*, Valerie M. Slee, RN, BSN4*, Susan Jennings, PhD4*, Celeste Finnerty, PhD4*, Linda Bohannon, RN, BSN, MSM5*, Susan Mathias, MPH6* and Mariana Castells, MD, PhD7*

1Mays Cancer Center at UT Health San Antonio, San Antonio, TX
2Blueprint Medicines Corporation, Cambridge, MA
3Biopharma Catalyst Consulting, Cambridge, MA
4The Mast Cell Disease Society, Sterling, MA
5Cancer Support Community, Washington, DC
6Health Outcomes Solutions, Winter Park, FL
7Brigham and Women’s Hospital, Boston, MA

Patrick Kuhlman, MD1, Donna Marie Williams, MD1*, Gregory B Russell, MS1*, Amy Amornmarn, MD1*, Joshua Harbaugh, DO1*, Ryan Richard Woods, MD2 and Thomas Lycan, DO1*

1Wake Forest School of Medicine, Winston Salem, NC
2Wake Forest School of Medicine, Winston-Salem, NC

Adam Cuker, MD1*, Jenny M. Despotovic, DO2*, Rachael F. Grace, MD3,4, Caroline Kruse5*, Michele P. Lambert, MD, MSTR6,7, Howard Liebman, MD8*, Roger M. Lyons, MD9, Keith R. McCrae, MD10, Vinod A. Pullarkat, MD11, Jeffrey Wasser, MD12*, David Beenhouwer, MD13*, Sarah N Gibbs, MPH13*, Irina Yermilov, MD, MPH, MS13* and Michael S Broder, MD, MSHS13*

1Department of Medicine, University of Pennsylvania, Philadelphia, PA
2Baylor College of Medicine, Houston, TX
3Harvard Medical School, Boston, MA
4Dana-Farber/Boston Children’s Cancer and Blood Disorders Center, Harvard Medical School, Boston, MA
5Platelet Disorder Support Association, Cleveland, OH
6Children's Hospital of Philadelphia, Philadelphia, PA
7Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA
8University of Southern California, Los Angeles, CA
9Texas Oncology/US Oncology Research, San Antonio, TX
10Cleveland Clinic, Cleveland, OH
11City of Hope, Duarte, CA
12University of Connecticut, Farmington, CT
13Partnership for Health Analytic Research (PHAR), LLC, Beverly Hills, CA

Lise Lurienne, PharmD1*, Clément Le Bescop1*, Renaud Buffet, MD2* and Pierre-Alain Bandinelli1*

1Da Volterra, PARIS, France
2Da Volterra, Paris, France

Lalita Norasetthada, MD1, Somchai Wongkhantee, MD2*, Jindaratn Chaipokam3*, Kanyaporn Charoenprasert, MD4*, Suporn Chuncharunee, MD5, Ponlapat Rojnuckarin, MD, PhD6, Chittima Sirijerachai, MD7*, Wanchai Wanachiwanawin, MD8* and Surapol Issaragrisil, MD9*

1Division of Hematology, Department of Internal Medicine, Faculty of Med., Chiang Mai University, Chiang mai, Thailand
2Division of Hematology, Department of Medicine, Khon Kaen Regional Hospital, Khon Kaen, Thailand
3Sakolnakorn Hospital, Sakolnakorn, Thailand
4Sisaket hospital, Sisaket, Thailand
5Division of Hematology, Department of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand
6Division of Hematology, Department of Medicine, King Chulalongkorn Memorial Hospital, Bangkok, Thailand
7Division of Hematology, Department of Medicine, Khonkaen University, Khonkaen, Thailand
8Division of Hematology, Department of Medicine, Faculty of Medicine, Siriraj Hospital, Mahidol University, Bangkok, Thailand
9Faculty of Medicine, Siriraj Hospital, Mahidol University, Bangkok, Thailand

Kevin E Todd Jr., MD1, Meghan E Mcgrady, PhD2*, Anne Blackmore, RN1*, Carrie Hennessey, RN3* and Lori Luchtman-Jones, MD4,5

1Cancer and Blood Diseases Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, OH
2Cincinnati Children's Hospital Medical Center and the University of Cincinnati College of Medicine, Cincinnati, OH
3Cincinnati Children's Hospital Medical Center, Cincinnati, OH
4Division of Hematology, Cancer and Blood Diseases Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, OH
5Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH

Ana Cristina Silva Pinto, MD, PhD1*, Fernando Ferreira Costa, MD, PhD2, Sandra Fatima Menosi Gualandro, MD, PhD3,4*, Patricia Belintani Blum Fonseca5*, Carolina Tosin Bueno, PhD6* and Rodolfo D Cançado7,8

1Blood Center of Ribeirão Preto, Ribeirão Preto Medical School, University of São Paulo, Brazil, Sao Paulo, Brazil
2School of Medical Sciences, University of Campinas, Campinas, SP, Brazil
3Department of Hematology, Clinics Hospital, University of São Paulo Medical School, São Paulo, Brazil
4Serviço de Hematologia, Hemoterapia e Terapia Celular - Hospital das Clínicas - Faculdade de Medicina da Universidade de São Paulo/Instituto do Câncer do Estado de São Paulo, Sao Paulo, Brazil
5Hospital Infantil Darcy Vargas, Sao Paulo, Brazil
6Novartis Oncology, Sao Paulo, Brazil
7Department of Hematology–Oncology, Santa Casa Medical School of São Paulo, São Paulo, Brazil
8Department of Hematology/Oncology, Santa Casa Medical School, São Paulo, Brazil

Lianne E Rotin, MD, PhD1, Auro Viswabandya, MD2,3, Rajat Kumar, MD2,3 and Kevin H.M. Kuo, MD, MSc, FRCPC2,4

1Internal Medicine Residency Program, Department of Medicine, University of Toronto, Toronto, ON, Canada
2Division of Hematology, Department of Medicine, University of Toronto, Toronto, ON, Canada
3Messner Allogeneic Transplant Program, Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada
4Division of Medical Oncology and Hematology, Department of Medicine, University Health Network, Toronto, ON, Canada

Emanuele Cerulli Irelli1*, Carlo Di Bonaventura, MD1*, Gianmarco Tessari2*, Tiziana Di Pippo3*, Rosaria Turchetta, MD4*, Stefano Ferracuti2*, Anna Teresa Giallonardo1*, Rocco Plateroti, MD5*, Luisa Cardarelli, MD3*, Daniela De Benedittis, MD3*, Sara Mohamed, MD3*, Giovanna Palumbo, MD3*, Francesca Caramia, MD1*, Marcella Nebbioso, MD5*, Patrizia Mancini, MD6* and Fiorina Giona, MD3

1Department of Human Neurosciences, Sapienza University of Rome, AOU Policlinico Umberto I, Rome, Italy
2Department of Neuropsychology, Sapienza University of Rome, AOU Policlinico Umberto I, Rome, Italy
3Department of Translational and Precision Medicine - Hematology Division, Sapienza University of Rome, Rome, Italy
4Department of Sense Organs, UOS Children Audiology, Sapienza University of Rome, AOU Policlinico Umberto I, Rome, Italy
5Department of Sense Organs, Sapienza University of Rome, AOU Policlinico Umberto I, Rome, Italy
6Department of Sense Organs Cochlear Implant Center, Sapienza University of Rome, AOU Policlinico Umberto I, Rome, Italy

Wendy Y Cheng, PhD, MPH1*, Sujata P. Sarda, PhD2*, Nikita Mody-Patel, PharmD, MBA3*, Sangeeta Krishnan, PharmD, MS2*, Mihran Yenikomshian, MBA1*, Patrick J. Scoble, PharmD3*, Colin Kunzweiler, PhD, MS1*, Jensen Duy Vu, BA1*, Hoi Ching Cheung, BA1* and Mei Sheng Duh, ScD, MPH1

1Analysis Group, Boston, MA
2Apellis, Waltham, MA
3Apellis Pharmaceuticals, Inc., Waltham, MA

Shoshana Revel-Vilk, MD, MSc1,2, Gabriel Chodick, PhD3*, Varda Shalev, MD4* and Noga Gadir, PhD5*

1Pediatric Hematology/Oncology Unit, Gaucher Unit, Hadassah Medical Center Hebrew University, Jerusalem, Israel
2Faculty of Medicine, Hebrew University, Jerusalem, Israel
3MaccabiTech, Tel-Aviv, Israel
4Institue Kahn-Maccabi for research and innovation, Maccabi Health Care Services, Tel-Aviv, Israel
5Takeda, Zurich, Switzerland

Carlos Bachier, MD1, David Eiznhamer, PhD2*, Andrew Milgroom, MS3*, Mara Lenco, MS3*, Nayan Patel, MS3* and Jeffrey Rolf Skaar, PhD4*

1Sarah Cannon Center for Blood Cancer at Tristar Centennial Medical Center, Nashville, TN
2Kadmon Corporation, LLC, New York, NY
3Trinity Life Sciences, Waltham, MA
4Trinity Life Sciences, New York, NY

Wendy Y Cheng, PhD, MPH1*, Sujata P. Sarda, PhD2*, Nikita Mody-Patel, PharmD, MBA2*, Sangeeta Krishnan, PharmD, MS2*, Mihran Yenikomshian, MBA1*, Patrick J. Scoble, PharmD2*, Malena Mahendran, MSc1*, Dominique Lejeune, MSc3*, Louise Yu, MSc1* and Mei Sheng Duh, ScD, MPH1

1Analysis Group, Boston, MA
2Apellis Pharmaceuticals, Inc., Waltham, MA
3Groupe d’analyse, Ltée, Montréal, QC, Canada

Miguel Gonzalez Velez, MD1, Carolyn Mead-Harvey, MS2*, Heidi E. Kosiorek, MS2*, Yael Kusne, MD, PhD3*, Leyla Bojanini, MD4*, Candido E. Rivera, MD5, Donald Northfelt, MD6*, Chung-II Wi, MD7* and Leslie Padrnos, MD8

1Hematology-Oncology Department, Mayo Clinic, Arizona, Phoenix, AZ
2Department of Health Sciences Research, Mayo Clinic, Scottsdale, AZ
3Internal Medicine Department, Mayo Clinic, Arizona, Scottsdale, AZ
4Mayo Clinic Florida, Jacksonville, FL
5Division of Hematology and Medical Oncology, Mayo Clinic, Jacksonville, FL
6Mayo Clinic, Phoenix, AZ
7Department of Pediatric and Adolescent Medicine, Mayo Clinic Minnesota, Rochester, MN
8Hematology-Oncology Department, Mayo Clinic Arizona, Phoenix, AZ

*signifies non-member of ASH